Close Menu

NEW YORK (GenomeWeb) – Bio-Techne today announced a strategic agreement with China's Lisen Imprinting Diagnostics Wuxi in the field of precision medicine.

Specifically, the partnership, Minneapolis-based Bio-Techne said, will accelerate the development of molecular diagnostics in the Chinese market. Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
10

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.